ロード中...
Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase
BACKGROUND: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of endothelial nitric oxide synthase (eNOS), is considered a risk factor for the pathogenesis of cardiovascular diseases. Simvastatin, a lipid‐lowering drug with other pleiotropic effects, has been widely used for treatment of c...
保存先:
| 出版年: | J Am Heart Assoc |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4843600/ https://ncbi.nlm.nih.gov/pubmed/27091343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.116.003327 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|